Search results
Results from the WOW.Com Content Network
Postcholecystectomy syndrome (PCS) describes the presence of abdominal symptoms after a cholecystectomy (gallbladder removal). Symptoms occur in about 5 to 40 percent of patients who undergo cholecystectomy, [1] and can be transient, persistent or lifelong. [2][3] The chronic condition is diagnosed in approximately 10% of postcholecystectomy cases.
Cholecystectomy is the surgical removal of the gallbladder. Cholecystectomy is a common treatment of symptomatic gallstones and other gallbladder conditions. [ 1 ] In 2011, cholecystectomy was the eighth most common operating room procedure performed in hospitals in the United States. [ 2 ]
Anesthesia. Postoperative nausea and vomiting (PONV) is the phenomenon of nausea, vomiting, or retching experienced by a patient in the post-anesthesia care unit (PACU) or within 24 hours following a surgical procedure. PONV affects about 10% of the population undergoing general anaesthesia each year. PONV can be unpleasant and lead to a delay ...
[26] Removal of the gallbladder with surgery, known as a cholecystectomy, is the definitive surgical treatment for biliary colic. [27] A 2013 Cochrane review found tentative evidence to suggest that early gallbladder removal may be better than delayed removal. [28] Early laparoscopic cholecystectomy happens within 72 hours of diagnosis. [13]
Bile duct obstruction, which is usually present in acute cholangitis, is generally due to gallstones. 10–30% of cases, however, are due to other causes such as benign stricturing (narrowing of the bile duct without an underlying tumor), postoperative damage or an altered structure of the bile ducts such as narrowing at the site of an anastomosis (surgical connection), various tumors (cancer ...
Each clinical practice guideline has been systematically researched, reviewed and revised by the SAGES Guidelines Committee and also evaluated by an appropriate multidisciplinary team. Guidelines are scheduled for periodic review to allow incorporation of pertinent new developments in medical research knowledge, and practice.
National Institute for Health and Care Excellence. The National Institute for Health and Care Excellence (NICE) is an executive non-departmental public body, in England, of the Department of Health and Social Care, [1] that publishes guidelines in four areas: guidance for social care services and users. These appraisals are based primarily on ...
Guidelines are available from the American Association for the Study of Liver Diseases (AASLD), American Association of Clinical Endocrinologists (AACE) National Institute for Health and Care Excellence (NICE), the European Association for the Study of the Liver (EASL), and the Asia-Pacific Working Party on NAFLD. [5] [7] [14] [66] [16] [78] [79]